Codagenix
Codagenix employs a proprietary technology platform for the construction of live attenuated viral vaccines for multiple targets. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€91—136m (Dealroom.co estimates Feb 2023.)
Oyster Bay New York (HQ)
Authorizing premium user...